YRA-1909

· Yungjin Pharm. Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for YRA-1909, covering 2021-05-03 to 2021-05-03. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Study to Evaluate the Safety and Efficacy of YRA-1909 in Patients With Rheumatoid Arthritis [Phase 2]